RecruitingNCT00899405

Studying Tumor Tissue Samples and Blood Samples to Learn More About DNA Changes in Patients With Lung Cancer

EGFR Pathway Mutations in Lung Cancer Patient Tumors and Blood

Sponsor

University of California, Davis

Enrollment

800 participants

Start Date

May 1, 2005

Study Type

OBSERVATIONAL

Conditions

Lung Cancer

Summary

RATIONALE: Studying samples of tumor tissue and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This laboratory study is looking at tumor tissue samples and blood samples to learn more about DNA changes in patients with lung cancer.

Eligibility

Min Age: 18 Years

Inclusion Criteria6

DISEASE CHARACTERISTICS:
Histologically or cytologically confirmed lung cancer
PATIENT CHARACTERISTICS:
Not specified
PRIOR CONCURRENT THERAPY:
May have received prior EGFR inhibitors

Locations(1)

University of California Davis Cancer Center

Sacramento, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT00899405

Related Trials

Studying Tumor Tissue Samples and Blood Samples to Learn More About DNA Changes in Patients With Lung Cancer

Conditions

Summary

Eligibility

Inclusion Criteria6

Locations(1)

Related Trials

Virtual Agent Feasibility in Oncology Patients (NTT Data)

A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies

Rhomboid Intercostal Block vs Erector Spinae Block

Lung Cancer Screening in HIgh Risk nonsmokErs by Artificial inteLligence Device

Study of Novel Treatment Combinations in Patients With Lung Cancer